Literature DB >> 23353925

Nitric oxide synthase inhibitors protect against rotenone-induced, oxidative stress mediated parkinsonism in rats.

K S Madathil1, S S Karuppagounder, R Haobam, M Varghese, U Rajamma, K P Mohanakumar.   

Abstract

Rotenone is known to cause progressive dopaminergic neuronal loss in rodents, but it remains unclear how this mitochondrial complex-I inhibitor mediates neurodegeneration specific to substantia nigra pars compacta (SNpc). One of the proposed mechanisms is increased free radical generation owing to mitochondrial electron transport chain dysfunction following complex-I inhibition. The present study examined the role of nitric oxide (NO) and hydroxyl radicals (OH) in mediating rotenone-induced dopaminergic neurotoxicity. Indications of NO involvement are evidenced by inducible nitric oxide synthase (NOS) over-expression, and increased NADPH-diaphorase staining in SNpc neurons 96h following rotenone administration. Treatment of these animals with specific neuronal NOS inhibitor, 7-nitroindazole (7-NI) and non-specific NOS inhibitor, N-ω-nitro-l-argenine methyl ester (l-NAME) caused reversal of rotenone-induced striatal dopamine depletion, and attenuation of the neurotoxin-induced decrease in the number of tyrosine hydroxylase immunoreactive neurons in SNpc, as well as in apomorphine and amphetamine-induced unilateral rotations. Interestingly, the study also demonstrated the contribution of OH in mediating rotenone nigral toxicity since there appeared a significant generation of the reactive oxygen species in vivo 24h following rotenone administration, a copious loss of reduced and oxidized glutathione, and increased superoxide dismutase and catalase activities in the cytosolic fractions of the ipsilateral SNpc area on the 5th day. An OH scavenging capacity of 7-NI and l-NAME in a Fenton-like reaction, as well as complete reversal of the rotenone-induced increases in the antioxidant enzyme activities, and the loss in reduced and oxidized glutathione contents in the SNpc supported OH involvement in rotenone-induced dopaminergic neurotoxicity. While these results strongly suggest the contribution of both OH and NO, resulting in acute oxidative stress culminating in dopaminergic neurodegeneration caused by rotenone, the course of events indicated generation of OH as the primary event in the neurotoxic processes.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23353925     DOI: 10.1016/j.neuint.2013.01.007

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  11 in total

1.  Curcumin Monoglucoside Shows Improved Bioavailability and Mitigates Rotenone Induced Neurotoxicity in Cell and Drosophila Models of Parkinson's Disease.

Authors:  M D Pandareesh; M K Shrivash; H N Naveen Kumar; K Misra; M M Srinivas Bharath
Journal:  Neurochem Res       Date:  2016-08-17       Impact factor: 3.996

2.  Interferon Gamma potentiates the injury caused by MPP(+) on SH-SY5Y cells, which is attenuated by the nitric oxide synthases inhibition.

Authors:  Simoneide S Titze-de-Almeida; Cátia Faria Lustosa; Camila Hillesheim Horst; Elaine Del Bel; Ricardo Titze-de-Almeida
Journal:  Neurochem Res       Date:  2014-10-09       Impact factor: 3.996

Review 3.  M1 and M2 immune activation in Parkinson's Disease: Foe and ally?

Authors:  M S Moehle; A B West
Journal:  Neuroscience       Date:  2014-11-25       Impact factor: 3.590

4.  Garcinia morella extract confers dopaminergic neuroprotection by mitigating mitochondrial dysfunctions and inflammation in mouse model of Parkinson's disease.

Authors:  Ankumoni Dutta; Banashree Chetia Phukan; Rubina Roy; Muhammed Khairujjaman Mazumder; Rajib Paul; Amarendranath Choudhury; Diwakar Kumar; Pallab Bhattacharya; Joyobrato Nath; Sanjeev Kumar; Anupom Borah
Journal:  Metab Brain Dis       Date:  2022-05-27       Impact factor: 3.655

Review 5.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

6.  Global loss of acetylcholinesterase activity with mitochondrial complexes inhibition and inflammation in brain of hypercholesterolemic mice.

Authors:  Rajib Paul; Anupom Borah
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

7.  Evaluation of the adaptogenic potential exerted by ginsenosides Rb1 and Rg1 against oxidative stress-mediated neurotoxicity in an in vitro neuronal model.

Authors:  Carlos Fernández-Moriano; Elena González-Burgos; Irene Iglesias; Rafael Lozano; M Pilar Gómez-Serranillos
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

8.  Attenuated levels of phospholipids in the striatum of rats infused with rotenone causing hemiparkinsonism as detected by simple dye-lipid complex.

Authors:  Margabandhu Gopi; Arambakkam Janardhanam Vanisree
Journal:  IBRO Rep       Date:  2017-06-13

9.  Inhibition of i-NOS but not n-NOS protects rat primary cell cultures against MPP(+)-induced neuronal toxicity.

Authors:  Monika J Brzozowski; Peter Jenner; Sarah Rose
Journal:  J Neural Transm (Vienna)       Date:  2014-12-13       Impact factor: 3.575

10.  Novel therapeutic targets in depression and anxiety: antioxidants as a candidate treatment.

Authors:  Ying Xu; Chuang Wang; Jonathan J Klabnik; James M O'Donnell
Journal:  Curr Neuropharmacol       Date:  2014-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.